Guardant Health
288 hedge funds and large institutions have $5.46B invested in Guardant Health in 2020 Q1 according to their latest regulatory filings, with 67 funds opening new positions, 113 increasing their positions, 70 reducing their positions, and 44 closing their positions.
61% more repeat investments, than reductions
Existing positions increased: 113 | Existing positions reduced: 70
52% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 44
7% more funds holding
Funds holding: 268 → 288 (+20)
1% more ownership
Funds ownership: 82.11% → 83.12% (+1%)
5% less call options, than puts
Call options by funds: $39.4M | Put options by funds: $41.2M
9% less capital invested
Capital invested by funds: $6.03B → $5.46B (-$570M)
46% less funds holding in top 10
Funds holding in top 10: 13 → 7 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ClearBridge Investments
New York
|
+$246M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
+$79.1M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$52.6M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$34M |
| 5 |
Chevy Chase Trust
Bethesda,
Maryland
|
+$27.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SUT
SC US (TTGP)
Menlo Park,
California
|
-$182M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$96.7M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$30.5M |
| 4 |
Millennium Management
New York
|
-$26.2M |
| 5 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$25.5M |
GH Hedge Fund Activity: Q1 2020 in Review
288 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q1 2020, worth a combined $5.46B — down 9.5% from $6.03B a quarter earlier.
Buyers outnumbered sellers: 67 funds opened new GH positions and 44 closed out — a net gain of 23 holders — while 113 added to existing stakes and 70 trimmed.
The largest buyer was ClearBridge Investments, adding an estimated $246M. The largest seller was SC US (TTGP), exiting entirely with an estimated $182M sold.
- 288 institutional investors held Guardant Health (GH) as of Q1 2020, up from 268 in Q4 2019.
- Funds reported $5.46B of Guardant Health stock for Q1 2020, down 9.5% quarter-over-quarter.
- 67 funds opened new Guardant Health positions in Q1 2020 and 44 closed out, a net change of +23 holders.
- The largest Guardant Health buyer in Q1 2020 was ClearBridge Investments, an estimated $246M added.
- The largest Guardant Health seller in Q1 2020 was SC US (TTGP), an estimated $182M sold.
Based on aggregated 13F filings for Q1 2020.